MedPath

Brain metabolite changes in MR-Spectroscopy in patients with relapsing-remitting and secondary progressive Multiple Sclerosis: two years follow up study

Conditions
G35.9
Registration Number
DRKS00009807
Lead Sponsor
niversitätsmedizin Göttingen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients were classified according to clinical course as having either recurrent relapses or secondary progressive disease course over a maximum period of two years prior to inclusion

Exclusion Criteria

cardiac Pacemaker, metal implants, Allergie to contrast agent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Timepoint of the disease with the most prominent tNAA reduction in MRS
Secondary Outcome Measures
NameTimeMethod
Korrelation of metabolite concentration with disability
© Copyright 2025. All Rights Reserved by MedPath